170 related articles for article (PubMed ID: 11884399)
1. P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA.
Lin X; Taube R; Fujinaga K; Peterlin BM
J Biol Chem; 2002 May; 277(19):16873-8. PubMed ID: 11884399
[TBL] [Abstract][Full Text] [Related]
2. Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.
Taube R; Lin X; Irwin D; Fujinaga K; Peterlin BM
Mol Cell Biol; 2002 Jan; 22(1):321-31. PubMed ID: 11739744
[TBL] [Abstract][Full Text] [Related]
3. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activity and substrate recognition of cyclin T2 from P-TEFb.
Kurosu T; Zhang F; Peterlin BM
Gene; 2004 Dec; 343(1):173-9. PubMed ID: 15563843
[TBL] [Abstract][Full Text] [Related]
5. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
Hoque M; Young TM; Lee CG; Serrero G; Mathews MB; Pe'ery T
Mol Cell Biol; 2003 Mar; 23(5):1688-702. PubMed ID: 12588988
[TBL] [Abstract][Full Text] [Related]
6. A model of repression: CTD analogs and PIE-1 inhibit transcriptional elongation by P-TEFb.
Zhang F; Barboric M; Blackwell TK; Peterlin BM
Genes Dev; 2003 Mar; 17(6):748-58. PubMed ID: 12651893
[TBL] [Abstract][Full Text] [Related]
7. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.
Napolitano G; Majello B; Licciardo P; Giordano A; Lania L
Gene; 2000 Aug; 254(1-2):139-45. PubMed ID: 10974544
[TBL] [Abstract][Full Text] [Related]
9. Interactions between fission yeast Cdk9, its cyclin partner Pch1, and mRNA capping enzyme Pct1 suggest an elongation checkpoint for mRNA quality control.
Pei Y; Schwer B; Shuman S
J Biol Chem; 2003 Feb; 278(9):7180-8. PubMed ID: 12475973
[TBL] [Abstract][Full Text] [Related]
10. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription.
Fu TJ; Peng J; Lee G; Price DH; Flores O
J Biol Chem; 1999 Dec; 274(49):34527-30. PubMed ID: 10574912
[TBL] [Abstract][Full Text] [Related]
11. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
[TBL] [Abstract][Full Text] [Related]
12. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.
Nguyen VT; Kiss T; Michels AA; Bensaude O
Nature; 2001 Nov; 414(6861):322-5. PubMed ID: 11713533
[TBL] [Abstract][Full Text] [Related]
13. VP16 and ubiquitin; binding of P-TEFb via its activation domain and ubiquitin facilitates elongation of transcription of target genes.
Kurosu T; Peterlin BM
Curr Biol; 2004 Jun; 14(12):1112-6. PubMed ID: 15203006
[TBL] [Abstract][Full Text] [Related]
14. Identification of a cyclin subunit required for the function of Drosophila P-TEFb.
Peng J; Marshall NF; Price DH
J Biol Chem; 1998 May; 273(22):13855-60. PubMed ID: 9593731
[TBL] [Abstract][Full Text] [Related]
15. Runx1 binds positive transcription elongation factor b and represses transcriptional elongation by RNA polymerase II: possible mechanism of CD4 silencing.
Jiang H; Zhang F; Kurosu T; Peterlin BM
Mol Cell Biol; 2005 Dec; 25(24):10675-83. PubMed ID: 16314494
[TBL] [Abstract][Full Text] [Related]
16. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
[TBL] [Abstract][Full Text] [Related]
17. Identification of multiple cyclin subunits of human P-TEFb.
Peng J; Zhu Y; Milton JT; Price DH
Genes Dev; 1998 Mar; 12(5):755-62. PubMed ID: 9499409
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
19. Catalytic activity of Cdk9 is required for nuclear co-localization of the Cdk9/cyclin T1 (P-TEFb) complex.
Napolitano G; Majello B; Lania L
J Cell Physiol; 2003 Oct; 197(1):1-7. PubMed ID: 12942536
[TBL] [Abstract][Full Text] [Related]
20. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.
Lu H; Yu D; Hansen AS; Ganguly S; Liu R; Heckert A; Darzacq X; Zhou Q
Nature; 2018 Jun; 558(7709):318-323. PubMed ID: 29849146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
